Rigel Pharmaceuticals Inc.

South San Francisco, CA

UEI
X7MHPBCMHFM3
CAGE
60TS7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Building 83, 611 Gateway Blvd UNIT 900, South San Francisco, CA 94080, USA
Website
rigel.com
Founded
1996
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 -$500,000
FY2023 $749,999

Contract vehicles

Contract awards

Similar vendors

Vendor Location Primary NAICS
Gilead Sciences Inc. UEI FPJMGUK1BYH8 Foster City, CA 325412 Pharmaceutical Preparation Manufacturing
60P UEI WKN5DNLTVF95 Washington, DC 325412 Pharmaceutical Preparation Manufacturing
Biotherapeutics, Inc. UEI DKZNEQL174E3 Blacksburg, VA —
Endo Usa, Inc. UEI D739PJVW5JF9 Malvern, PA 325412 Pharmaceutical Preparation Manufacturing
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3 Deerfield, IL 325412 Pharmaceutical Preparation Manufacturing

About the company

Rigel Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing novel small molecule drugs for the treatment of inflammatory diseases, autoimmune diseases, and serious viral infections. It was founded in 1997 and is headquartered in South San Francisco, California.

Rigel Pharmaceuticals has received several prime federal contract awards from agencies such as the Department of Health and Human Services, the Department of the Army, and the Department of Veterans Affairs. In 2023, it was awarded a $749,999 firm-fixed-price contract by the Office of the Assistant Secretary for Preparedness and Response to evaluate the impact of its drug fostamatinib on long-term outcomes in patients with Acute Respiratory Distress Syndrome (ARDS). Additionally, in 2021, the company received a $16.5 million Other Transaction Agreement from the Joint PEO Chemical and Biological Defense to support the development of a therapeutic for treating COVID-19. These awards demonstrate Rigel's expertise in developing treatments for respiratory diseases and viral infections.

Rigel Pharmaceuticals also holds a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. This multiple-award contract, valued at $19,516,920, provides drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The contract aims to ensure that the Veterans Health Administration's medical centers and clinics have reliable access to necessary pharmaceutical treatments and supplies, including Rigel's FDA-approved hematology treatments, over a five-year period until October 2028. This contract highlights Rigel's role as a supplier of critical medical products to the federal government's healthcare system.

Quick answers

Is Rigel Pharmaceuticals Inc. registered in SAM.gov?

Yes. Rigel Pharmaceuticals Inc.'s SAM.gov registration is active through December 10, 2026.

Which contract vehicles does Rigel Pharmaceuticals Inc. hold?

Rigel Pharmaceuticals Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

How much has Rigel Pharmaceuticals Inc. received in federal contracts?

Federal contracts obligated $249,999 to Rigel Pharmaceuticals Inc. in fiscal years 2023 through 2027.

What is Rigel Pharmaceuticals Inc.'s most recent federal award?

Rigel Pharmaceuticals Inc.'s most recent federal contract award is Rigel pharmaceuticals: the overall objective of this contract is to evaluate the impact of fostamatinib treatment… (75A50123C00012), from Office of the Assistant Secretary for Preparedness and Response, on May 1, 2023.

On GovTribe

See Rigel Pharmaceuticals Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors